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B  lymphocytes  use  immunogiobulins  (Ig)  as  both  membrane  receptors  for 
antigens  and  as  secretory  products.  The  membrane-associated  and  secretory 
forms of # heavy (H) 1 chains are specified by mRNAs that are transcribed from 
a  single gene that  contains alternative  secretory and membrane  exons at its 3' 
end (1-6).  Studies using tumor cells of B cell lineage have shown a  correlation 
between the secretory state of the cell and the ratio of mRNA for the membrane 
form of the ~H chain (/~m mRNA) to mRNA for the secretory form of the tzH 
chain (~s mRNA) (2-4,  7, 8).  Indeed, in BCLI B lymphoma cells, which may be 
stimulated by a B cell differentiation factor to change from a nonsecretory state 
to a state of IgM secretion, a change in the ratio of/zs//~m mRNA and an increase 
in #s mRNA occur as the cells initiate IgM secretion (9). 
Recently, Lamson and Koshland (10) have shown similar changes in normal B 
cells stimulated with lipopolysacchride (LPS). Their results indicated that resting 
B  cells  expressed  principally  ~m  mRNA,  and  that  amplification  of #s  mRNA 
occurs after  72  h  in culture, just before the  beginning  of IgM  secretion.  The 
appearance of us mRNA is correlated with the appearance of mRNA forJ chain, 
a molecule key to the formation of pentameric IgM, whose expression is closely 
associated with IgM secretion (8,  10,  11). 
We  have  recently  (12,  13)  developed a  system  in  which  B  cell  activation, 
proliferation,  commitment  to IgM secretion, and entry into the IgM secretory 
state are separately controlled events.  Normal resting B cells Cultured with low 
concentrations  of anti-IgM  antibody are activated,  and  will  proliferate,  in  the 
presence of B  cell  stimulatory  factor (BSF)-pl  (14) (formerly designated  B cell 
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growth factor; 15). The development of these cells into cells synthesizing IgM at 
high rates depends upon the action of two additional T  cell products (13).  One 
of these, B 15-TRF (T cell-replacing factor), which is found in the supernatant 
of the B 151 K 12 T  cell hybridoma (16), is required early in culture and appears 
to be associated with the commitment of B cells to differentiation. The second 
factor, EL-TRF, found in supernatants of induced EL-4 cells, is required late in 
the culture and causes differentiation of appropriately prepared  B cells into an 
IgM-secreting  state  (13).  Recently,  we  have  shown  (17)  that  induced  EL-4 
supernatants contain two distinct molecules with EL-TRF activity. One is inter- 
leukin 2  (IL-2); the second is a  32,000  dalton molecule that lacks IL-2 and 3,- 
interferon activity. 
This system allows a  detailed study of the relationship between each step in 
the B cell response process and the appearance of mRNA involved in the secretion 
of IgM.  In this paper,  we have examined levels of Um mRNA, tts mRNA, and 
total #H chain mRNA, as well as J  chain mRNA and K chain mRNA in resting B 
cells, and of anti-IgM-stimulated B cells that have been cultured with various T 
cell-derived  growth  and  differentiation  factors.  Our  results  indicate  that  a 
striking induction of tts mRNA and J  chain mRNA, and an increase in the tts/ttm 
mRNA ratio occur at the end of the response process, when all T  cell-derived 
growth and differentiation factors have acted upon these cells. No major specific 
changes are detected in cells that have completed only a part of the total response. 
Materials and Methods 
Mice.  BALB/c mice were obtained from The Jackson Laboratory, Bar Harbor, ME, 
and used at 8-12 wk of age. 
Reagents.  Affinity-purified goat anti-mouse IgM antibody was prepared as previously 
described (18). 
Culture Medium.  RPMI 1640 (Biofluids, Rockville, MD) supplemented with 10% fetal 
calf serum (FCS), penicillin (50 ug/ml), streptomycin (50 #g/ml), gentamycin (100 ttg/ml), 
L-glutamine (2 raM),  and 2-mercaptoethanol (2-ME) (5  ×  10  -S M), was used as culture 
medium in  these experiments.  In  the  preparation  of EL-4  supernatants,  RPMI  1640 
medium containing 1% FCS, with supplements described above, was used. 
Factor Preparation.  EL-4 supernatant was prepared by culturing a cloned subline of 
EL-4 thymoma cells (2 ×  106/ml) with 10 ng/mi of phorbol myristate acetate (PMA) for 
48 h (19). Cell-free supernatant was collected and PMA was removed as described (14). 
Partially purified BSF-pl and EL-TRF were obtained from this cell-free supernatant by 
phenyi-Sepharose column chromatography (13, 20). BSF-pl was also purified by reverse 
phase high pressure liquid chromatography (HPLC). Its preparation will be described in 
detail elsewhere.  2 BSF-pl activity was tested in a B cell costimulator assay (14). B 15-TRF 
is the culture supernatant of B 151K 12 T hybridoma cells (16). Molecularly cloned human 
IL-2, purified by HPLC, was kindly provided to us by Dr. J. Farrar, Hoffmann-LaRoche, 
Inc., Nutley, NJ. IL-2 activity was measured by the stimulation of uptake of [SH]thymidine 
by an IL-2-dependent cell line (HT-2) (21). One unit of IL-2 is defined as the reciprocal 
of the dilution required to cause half-maximal proliferation of 4 ×  10  s HT-2 cells. 
B Cell Preparation.  We prepared B cells by pretreating donor mice with anti-thymocyte 
serum, followed by passing spleen cells over a Sephadex G10 column, and two rounds of 
complement-mediated lysis with monoclonal antibodies (mAb) anti-Thy-1.2 and anti-Lyt- 
1.2 (22). 
Assay for IgM-synthesizing Cells and J  Chain Production in Stimulated B Cells.  2 ×  10  s 
purified B cells were cultured in flat-bottom, 96-well microtiter plates (Costar 3596) in 
20hara, J., B. Fox, H. Quill, J. K. Inman, S. Lahet, and W. E. Paul. Manuscript in preparation. 1738  Ig  RNA  EXPRESSION IN  STIMULATED  B CELLS 
0.2  ml  of medium  containing 5  #g/ml  of goat anti-IgM  and  various combinations of 
factors.  After  4  d  in  culture,  the  presence  of cytoplasmic  IgM  was  determined  by 
immunofluorescence as previously described (13). The amounts of cellular J  chain were 
determined on day 4 by radioimmunoassay (23). 
Cell Lines.  The plasmacytomas MOPC-104E (#, ~i) and MOPC-315 J (a, ~2) (provided 
by  Dr.  R.  Lynch,  University of Iowa  College of Medicine,  Iowa  City,  IA),  and  the 
lymphoma  L10A  (#,  ~,)  (given  to  us  by  Dr.  R.  Asofsky,  NIH,  Bethesda,  MD),  were 
maintained in tissue culture in RPMI  1640 containing 10% FCS, antibiotics, 5  x  10  -5 M 
2-ME, and 2  mM  L-glutamine. All cell lines were used for preparation of cytoplasmic 
RNA. L10A cells were also used to obtain oligo(dT)-selected mRNA. 
DNA Probes.  The #m-specific probe was made by digestion of the genomic DNA clone 
#M8A with HindIII to yield a 2.5 kilobase (kb) fragment of the #H gene, containing the 
membrane, but not the secretory portion of the gene (P.  Early, unpublished data). We 
prepared from this a Kpn 1-Pst  1 fragment of 731 base pairs (bp). This fragment lacks 
several repetitive sequences present in the 2,5 kb fragment (24) and hybridizes only with 
the membrane exon of the #H gene and portions of the flanking introns; it was designated 
#m (Fig.  1A). 
A  secretory  type  #H  gene-specific  probe  was  subcloned  from  the  cDNA  clone 
p104E#12, p104E#12 was kindly provided by Dr. R. Wall, UCLA School of Medicine, 
Los Angeles, CA. We first digested p104E#12 with Pst 1. This Pst 1 fragment was further 
digested with Sau 3AI to yield a  191  bp fragment containing the secretory portion and 
3'  untranslated segment of the secretory form of #m mRNA.  The resultant Pst  1-Sau 
3AI fragment was inserted into the plasmid pUL9. This plasmid specifically hybridizes 
with mRNA of the secretory form and was designated #,. The #cH (# heavy chain constant 
region) cDNA probe, kindly provided by Dr. K. Marcu (State University of New York, 
Stony Brook, NY), contained the coding regions for CH~ to CH4 (25) (Fig.  1); it was used 
to detect both types of # mRNA. 
To detect J chain-specific sequences, the cDNA insert from the clone pJc21 was used 
for hybridization (26). The properties of this clone have been described. The x light chain 
probe,  kindly  provided  by  Dr.  R.  Wall,  is  a  recombinant  plasmid  containing  ~600 
nucleotides of x light chain mRNA sequences, including the entire constant region and 
<100 nucleotides of the K light chain variable region (27).  The cDNA clone pMHC-1, 
encoding amino acids 66-286 of the H-2L  d molecule, prepared by G. A. Evans et al. (28), 
was provided by Dr. D. H. Margulies (National Institute of  Allergy and Infectious Diseases, 
NIH), and was used for detection of L  d mRNA expression in B cells. DNA plasmids and 
fragments to be used for hybridization were [s2P]-iabeled by nick translation (29). 
Isolation  of Cytoplasmic RNA.  Cultured  cells  were collected and  washed twice with 
chilled Dulbecco's phosphate-buffered saline (Dulbecco's PBS), and cytoplasmic RNA was 
prepared as described (30). Briefly, cells were resuspended in ice-cold 0.14 M NaCi/0.01 
M Tris-HCl, pH 8.4, and 0.0015 M MgCI2 containing 250 #g of heparin and 250 #g of 
spermidine per ml, and lysed by the addition of Nonidet P-40 (NP-40) to 0.5%. After the 
nuclei were removed from the lysate by centrifugation, cytoplasmic RNA was obtained 
by sequential  extraction,  twice with  phenol, and  once in  chloroform/isoamyl alcohol 
(24:1). Cytoplasmic RNA was precipitated from solution in 70% ethanol at -20°C and 
then dissolved in 10 mM Tris-HC1, pH 7.4 and 1 mM EDTA. Poly(A)  + RNA was prepared 
from cytoplasmic RNA by using an oligo(dT) cellulose column. Sterile siliconized tubes 
were  used  in  all  steps  to  avoid  nonspeciflc binding  of RNA  and  to  minimize  RNA 
degradation. 
Dot  Blotting  of Cytoplasmic  RNA  onto  Nitrocellulose  Filters.  Cytoplasmic  RNA  was 
denatured by heating at 60°C for 15 min in the presence of 7.4% formaldehyde. Each 
sample was serially diluted with  15× SSC (IX SSC is 0.15 M NaCI in 0.015 M sodium 
citrate) and was blotted onto nitrocellulose paper with a suction manifold, fixed by baking, 
and then used for hybridization. 
Northern  Blot Analysis  of Poly(A)  + RATA and  Cytoplasmic RNA.  Poly(A)  +  RNA  and 
cytoplasmic RNA was denatured by heating at 60°C for 15 min in the presence of 50% 
(vol/vol) formamide, 20% (vol/vol) formaldehyde, and MOPS buffer (0.02 M morpholi- NAKANISHI  ET  AL.  1739 
FIGURE  1.  (A)  Restriction map of the  C~ gene.  The  upper  map illustrates the  genomic 
restriction map of C~. Open boxes represent exons; horizontal lines designate introns. Shaded 
boxes are 3' untranslated sequences present in either ~  or ~  mRNA. The lower portion of 
the figure shows DNA used as probes for hybridization, t~ca [pU (3741)] is a cDNA probe that 
commences at the end of the C~I and terminates near the end of C#4. ta is a  191  bp cDNA 
clone containing a  part of the secretory region, the 3' untranslated region, and a  synthetic 
DNA composed of a linker and the reconstituted plasmid Pst 1 site. t~s is a 731 bp Kpn 1-Pst 
1 fragment of the genomic DNA clone #M8A. (B) Cytoplasmic polyadenylated RNA from 
L 10A was subjected to electrophoresis through a 0.8% formaldehyde/agarose gel, transferred 
t32  to nitrocellulose filters, and hybridized with  P-labeled P-CH, t~m, or ~  probes. (C) RNA from 
MOPC-104E,  MOPC-315 J,  and  L10A  was  dotted  onto  nitrocellulose filters.  Dots  were 
hybridized with s'P-labeled t~,. and t~ probes. Autoradiographs were made by exposing x-ray 
film to these dots. Exposures for ucH were 20 h in duration; #m and t~ were exposed for 56 h. 
nopropanesulfonic acid, 5  mM sodium acetate,  0.5 mM EDTA), followed by cooling on 
ice. This denatured RNA was mixed with 1/10th volume of loading dye (50% glycerol and 
0.5% bromophenol blue), and then applied to a  0.8% agarose  horizontal gel containing 
1.2  M  formaldehyde  (31).  The  sample  was  electrophoresed  at  30-40  V  for  16  h, 
transferred to nitrocellulose paper, and baked 2  h  at 80 o  C  under negative pressure. 1740  Ig  RNA  EXPRESSION  IN  STIMULATED  B  CELLS 
Hybridization with Probes and Autoradiography.  After incubation of nitrocellulose filters 
with nick-translated plasmid DNA or DNA fragments for 16 h at 45°C, the filters were 
rinsed in 2X SSC and 0.1% (wt/vol) sodium dodecyl sulfate (SDS) at room temperature 
for 30 min. This was followed by two washes in the same buffer for 30 min at 60°C and 
two washes in the 0.2x SSC and 0.1% (wt/vol) SDS for 30 rain at 60°C. Kodak XAR-5 
x-ray film was exposed to the filters for 1-3 d at -70°C, using intensifying screens to 
obtain autoradiographs.  The resultant autoradiographs were scanned with a densitometer. 
Results 
Specificity olios and #m Probes.  We wished to verify the specificity of our probes 
for the membrane and secretory forms of #H mRNA. The ~  probe is a cDNA 
subclone, derived in our laboratory from p104E#12  (1),  and the #m probe is a 
Kpn 1-Pst  1 fragment derived from the genomic clone/~M8A (Fig. 1A).  When 
analyzed by Northern blotting, ~m hybridized with a  poly(A)  + RNA of 2.7  kb 
while #~ hybridized with 2.4 kb material, consistent with the established sizes for 
~,,, and/~ mRNA (1-6). #cn, a cDNA probe complementary to the CH~ to CH4 
domains of the ~H chain gene, hybridized with both forms of mRNA (Fig. 1B). 
Both #~ and #m hybridized extensively with cytoplasmic RNA from MOPC-104E 
and  L10A,  both  of which  express  IgM.  /~m  failed  to  hybridize  at  all  with 
cytoplasmic RNA from MOPC-315 J, an a,  ~,2 plasmacytoma, from which the 
genomic #H chain gene has been deleted, while ~  hybridized to a minor degree 
to  MOPC-315J  RNA  (Fig.  1C).  This  small  degree  of hybridization was  not 
observed under more stringent washing conditions. 
Changes in #~ and #~ mRNA Expression in B Cells Stimulated with Anti-IgM and 
T  Cell-derived  Factors.  Resting B cells were cultured in the presence of anti- 
IgM and BSF-pl. B 15-TRF and/or EL-TRF were added to some cultures. At 4 
d,  cells  were collected, and cytoplasmic RNA  was extracted and dotted onto 
nitrocellulose paper.  In  each  case,  the  initial  dot  contained  10  #g  of RNA; 
subsequent dots contained twofold dilutions of this. The yield of RNA from B 
cells cultured with anti-IgM and BSF-pl, with or without EL-TRF, was similar. 
Cultures containing B 15-TRF yielded about half as much RNA as those contain- 
ing anti-IgM and BSF-pl  without B15-TRF. We also dotted 10 ~g RNA from 
L 10A cells and from freshly isolated resting B cells.  It should be noted that the 
yield of RNA from resting B cells is much lower (5-10-fold) than that from each 
of the activated B cell populations. 
Fig.  2  presents autoradiographs of the hybridized dots, and Fig.  3  presents 
quantitative  analysis of these  autoradiographs  using  densitometry tracing  to 
evaluate the relative intensity of individual dots hybridized with #m or #~. B cells 
stimulated with anti-IgM and BSF-pl  display an -2.8-fold enhancement in the 
expression of ~,, mRNA when compared with resting B cells.  Since this compar- 
ison is based on fixed amounts of cytoplasmic RNA, and the yield of cytoplasmic 
RNA from resting B cells is 1/5-1/10 that obtained from stimulated B cells,  these 
results indicate that, on a per cell basis,  a marked enhancement in expression of 
#m  mRNA  occurs.  When we  made direct  comparisons, based  on amounts of 
cytoplasmic RNA from the same number of B cells, we found enhancements of 
8-16-fold in #,1 mRNA expression in B cells stimulated with anti-IgM and BSF- 
p 1. Adding B 15-TRF, EL-TRF, or both caused little or no change in ~m mRNA NAKANISHI  ET  AL.  1741 
FIGURE 2.  Cytoplasmic  dot-blot  hybridization  with  t~m  and  #,.  B  cells  were  prepared  as 
described  in  Materials and  Methods.  2  x  l0  s  B  cells were cultured in  0.2  ml of medium 
containing 5 #g/ml ofanti-IgM and various combinations of cofactors. Such ceils were cultured 
alone, or with BSF-p1  (reverse phase HPLC-purified material from induced EL-4 supernatant, 
containing 40 U of BSF-p 1/ml), B 15-TRF (equivalent to 125% of supernatant from B 151K 12 
hybridoma cells), and EL-TRF (5% of an IL-2-rich phenyI-Sepharose fraction of EL-4 super- 
natant, containing 80 U of IL-2/ml) either individually or in various combinations. After 4 d 
of incubation, cultured B cells of each group were pooled and washed twice with cold PBS. 
Cytoplasmic RNA was prepared from cultured and resting B cells by NP-40 lysis, sequential 
extraction with phenol and chloroform/isoamylalcohol (24:1),  followed by ethanol precipita- 
tion.  The initial dots contained  10  #g of RNA and  subsequent  dots contain serial twofold 
dilutions of this. Two replicas were made from each sample, of which one was hybridized with 
#m and the other with #~. 
expression,  compared with the change  in cytoplasmic RNA levels from B cells 
stimulated with only anti-IgM and BSF-pl. 
#s  mRNA  levels,  on  a  constant  cytoplasmic  RNA basis,  are  very similar  in 
resting B cells compared with B cells that have been stimulated with anti-IgM or 
BSF-pl  plus B15- or EL-TRF.  Addition  of all three factors causes an enhance- 
ment of 20-26-fold in #s mRNA expression.  Indeed, as shown in Table I, this 
marked  enhancement  in  /~s expression  correlates  with  the  appearance  of cells 
with  cytoplasmic  IgM.  When  compared  on  a  per cell  basis,  B  cells stimulated 
with  anti-IgM  and  all  three  factors  display  an  increase  in  tzs  mRNA  levels of 
170-fold over resting B cells (Table I). This increase is similar in magnitude to 
the increase in Ix, mRNA levels observed in LPS-activated cells (10). 
The ratio of/~/tZm mRNA in each of these cell populations can be estimated 
by reference to the ~ts/t~m mRNA ratios in cytoplasmic RNA of L10A cells.  A 
Northern  blot analysis of cytoplasmic  RNA from  L10A  cells,  hybridized  with 
~tcH, is presented in Fig.  4. The relative intensity of the #~ (2.4 kb) and ~tm (2.7 
kb)  species  (determined  by  densitometry  tracing)  was  1.22.  Since  the  same 
preparation of L 10A cytoplasmic RNA was included in the dot blotting experi- 
ment illustrated  in Figs.  2 and  3, we could use the known /Z,//Zm ratio of L10A 
RNA, together with the expression of~,, and of/zs in each cell population relative 
to that in L 10A cells, to calculate ~ts/tZm ratios for these RNA. Based on this, we 
observed ~tJ#m ratios of 0.31-0.40  in RNA from B cells treated with anti-IgM, 
or  BSF-pl  alone,  or with  B15- or  EL-TRF.  When all  three  T  cell factors are 
present, a tzd/~m ratio of 5.6 is obtained. 1742  Ig RNA  EXPRESSION  IN  STIMULATED B  CELLS 
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FIGURE 3.  Densitometery  scanning of RNA dots.  Autoradiographs  were scanned  with a 
densitometer and recorded, on the ordinate, relative to that of the 5-/~g dot from L 10A cells, 
which was assigned a value of 100%. Dilutions yielding 30% relative intensity were used to 
compare #, and #,. RNA content. 
Changes in Expression of  J Chain mRNA and Protein in Stimulated B  Cells.  It 
has been  shown  (8,  10,  11,  32,  33) that  IgM secretion,  in both  transformed  B 
cell lines and  LPS-stimulated normal B cells, is dependent  upon expression of J 
chain mRNA and protein.  To allow a  more precise examination of the relation- 
ship between J  chain synthesis and IgM secretion, we examined the control of J 
chain  expression  in  B  cells  stimulated  with  anti-IgM  and  the  T  cell-derived 
growth and differentiation  factors.  In these experiments, we compared mRNA 
expression, based on a  constant number of B cells.  Resting B cells have a  barely NAKANISHI  El"  AL. 
TABLE  I 
Change of Ratio of#. and tZm mRNA in Anti-lgM-stimulated  B Cells 
Percent cyto-  Relative 
Conditions of B cell  plasmic IgM  +  content (%)  t~u/t~ 
stimulation  cells  Ratio 
Resting B cells  NT  24  13  0.66 
Anti-IgM +  BSF-pl  0.5  67  17  0.31 
Anti-IgM +  BSF-pl +  B15-  0.7  75  22  0.36 
TRF 
Anti-IgM +  BSF-pl +  EL-  0.4  67  22  0.40 
TRF 
Anti-IgM +  BSF-pl +  B15-  20.7  96  440  5.59 
TRF +  EL-TRF 
LIOA  NT  100  100  1.22 
Relative content of RNA hybridizable with #= and v~ was determined by 
densitometry as shown in Fig.  3. th/t~ ratios were calculated based on a 
V,J#m ratio of 1.22 for LIOA cytoplasmic RNA, shown in Fig. 4. NT, not 
tested. In these experiments, similar amounts of cytoplasmic RNA were 
"dotted" in each group. The yield of RNA per resting B cell was 5-10- 
fold less than that of stimulated cells. Thus, the increase in #= and ~  RNA 
between resting and activated B  cells,  on a  per cell basis,  is 5-10-fold 
greater than that calculated from relative ~  and #~ content. 
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FIGURE 4.  Northern blot analysis of L10A cytoplasmic RNA. Cytoplasmic RNA (5 and 10 
#g) from L 10A was electrophoresed through a 0.8 % formaidehyde/agarose gel. After transfer 
to a nitrocellulose filter, the RNA was hybridized with sip-labeled #cx probe. The sizes of the 
two #  mRNAs  were  deduced  from  calibration with ribosomal RNA  markers visualized by 
ethidium bromide staining. The autoradiograph was scanned and the relative intensities of 
these two bands were determined to be 1.22. 
detectable level of J  chain  mRNA (Fig.  5).  Stimulation  with anti-IgM and BSF- 
pl  causes a  2-4-fold enhancement  in this level; addition of EL-TRF causes no 
further  enhancement  in J  chain  mRNA,  while  addition  of B15-TRF causes a 
slight increase.  However, if both B15- and EL-TRF are added to B cells already 
stimulated with anti-IgM and BSF-pl, a further 4-8-fold enhancement inJ chain 1744  Ig  RNA  EXPRESSION IN  STIMULATED  B  CELLS 
FIGURE 5.  Expression of  J chain mRNA in stimulated B cells. 2 × l0  B  B cells were cultured 
with anti-IgM and various combinations of T cell-derived factors for 4 d. Cytoplasmic RNA 
was prepared from 107 B cells by NP-40 lysis followed by phenol and chloroform/isoamylal- 
cohol (24:1) extraction. In each case, the initial dot contained cytoplasmic  RNA obtained from 
1.25 x  106 B cells. Subsequent dots contained serial twofold dilutions of this. Five replicas 
were made and were hybridized with five  different probes (J chain probe in Fig. 5; ~ chain 
probe in  Fig. 7;  L  d probe in  Fig. 8; ~, and ucH were also used but data are not shown). 
Simultaneously, each culture was examined for percentage of cells with cytoplasmic IgM and 
for J  chain protein  content  (Fig. 6B). The BSF-p1 used in this experiment  was a phenyl- 
Sepharose fraction of EL-4 supernatant. 
mRNA is observed. To examine the correlation between J  chain mRNA expres- 
sion and #s mRNA  expression,  we compared replica dots that were hybridized 
with  either  us  or  the J  chain  probe.  The  result  showed  a  strong  correlation 
between the expression of these two genes (data not shown). 
The enhancement  in J  chain  mRNA  synthesis  correlates very well  with  the 
presence of  J  chain protein in stimulated B cells. There was insufficient J  chain 
to precisely quantitate (Fig. 6), except in cells grown in the presence of all three 
stimulatory factors, where there was a substantial enhancement in the expression 
of  J  chain.  Indeed, these stimulated B cells had a J  chain content similar to that 
of the BALB/c plasmacytoma MOPC-104E. The induction of  J  chain expression 
correlated very well not only with the expression of ~s mRNA but also with the 
appearance of cells with cytoplasmic IgM. 
Changes in Expression of K Chain mRNA and mRNA for Class I Major Histocom- 
patibility  Complex (MHC)  Antigens.  To  further  examine  the  induction  of  Ig 
mRNA  in  the course of B  cell responses,  we probed dot blots with a  K-specific 
cDNA probe.  This experiment used replica blots of those probed with J  chain 
cDNA in  Fig.  5; a  constant number of cells was compared.  We observed a  low 
level of K mRNA  in  resting  B  cells and a  4-8-fold induction  upon  stimulation 
with anti-IgM and BSF-pl, with no further changes when B15- or EL-TRF was 
added (Fig. 7). In the presence of all three factors, there was a substantial increase 
(about fourfold), to levels comparable to that of MOPC-104E cells.  In general, 
changes  in  expression  of K mRNA  closely paralleled  changes  in  expression  of 
total #  mRNA, as detected with #cu (data not shown). 
Additional replicas of these dots were hybridized with a cDNA specific for the 
class I  MHC gene L d, in order to provide information on changes in expression 
of mRNA  for  a  molecule  not  known  to  be  involved  in  the  process  of B  cell 
proliferation or differentiation. As shown in Fig.  8,  B cells stimulated with anti- NAKANISHI  ET  AL.  1745 
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FIGURE 6.  Analysis of J chain protein production by B cells stimulated with anti-lgM and T 
cell-derived  factors.  B  cells  were  cultured  with  anti-IgM  and  T  cell-derived  factors.  Cell 
lysates were made by NP-40 (1%) lysis. Such lysates were examined for their capacity to inhibit 
the binding of I~I-J chain to goat anti-J chain antibodies. The abscissa  represents the amounts 
of J  chain  (for  standard  preparations)  or  number of cell  equivalents  (for  cell  lysates);  the 
ordinate represents the percent inhibition. A and B are separate experiments.  In B, the B cells 
used are the same as used for analysis of J chain mRNA expression shown in Fig.  5. 
FIGURE 7.  Expression of K  chain mRNA in stimulated B cells. One of the replicas described 
in Fig. 5 was hybridized with the • chain probe. 
IgM and BSF-pl  display an eightfold increase  in levels of L a mRNA compared 
with resting B cells.  This suggests that changes in levels of p, J chain, and K light 
chain  mRNA  found  in  activated  compared  with  resting  B  cells  may  not have 
significance specific to the activation process. Levels of L a mRNA do not change 
upon further addition  of T  cell  factors,  including  situations in  which  all  three 
factors are present.  This indicates  that the increase  of #,, J, and K mRNA,  and 1746  Ig  RNA EXPRESSION IN  STIMULATED B CELLS 
FIGURE 8.  Expression  of L  a mRNA in stimulated B cells. A replica of the filters used in Fig. 
5 and Fig. 7 was hybridized with a cDNA  probe complementary  to L  d molecule. 
the  changes  in  the  /ds/,t/, m  ratios  in  such  cases,  are  specifically  related  to  the 
differentiation process. 
Time Course of Induction of #s and J  Chain mRNA.  To  further  examine  the 
relation between synthesis of #~ and J  chain mRNA, and between the expression 
of these mRNAs and the induction of high rate IgM synthesis, we examined the 
time  course  of expression  of #~  and J  chain  mRNA  and  the  appearance  of 
cytoplasmic IgM  + cells among cells that had been stimulated with anti-IgM, BSF- 
pl, B15- and EL-TRF (Fig. 9). In these experiments, we used molecularly cloned 
human IL-2 as a source of EL-TRF (17). Levels of ~  mRNA that exceeded those 
found in B cells cultured with anti-IgM and BSF-p1 (with or without B15-TRF), 
were first detected at 72 h of culture with anti-IgM and all three factors. At that 
time, the percentage of cells with cytoplasmic IgM was only slightly greater than 
in  control  populations.  By  96  h,  a  striking  increase  in  #~  mRNA  occurred, 
depending  on  the  concentration  of IL-2  present.  A  striking  increase  in  the 
percentage of cells with cytoplasmic IgM was also observed. Changes in levels of 
J chain mRNA were closely correlated to those of~q mRNA, in terms of the time 
after  initiation  of culture  and  in  the  concentrations  of IL-2  required  for  the 
observed increases (Fig.  9).  These  results  strongly reinforce the concept of an 
intimate  relationship between #s and J  chain  mRNA expression and IgM secre- 
tion. 
Discussion 
Several investigators (1-8) have found a correlation between the IgM secretory 
state in tumors of the B cell lineage and high  levels of mRNA for #s, as well as 
high ~s/Um mRNA ratios.  Furthermore,  IgM synthesis, induced by LPS (10) in 
normal B cells, and by B cell differentiation factor (BCDF~) in the B lymphoma 
BCL-1  (9), is associated with striking increases in #s mRNA and with changes in 
~/~m ratios. Our current experiments examine the relationship between changes 
in ~s, urn, and related mRNA, and a high IgM synthesis rate in a system where it 
is  possible  to  bring  normal  cells  to  various  stages  along  the  B  cell  response 
pathway by controlling which growth and differentiation factors are provided in 
tissue culture. NAKANISHI  ET  AL.  1747 
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FIGURE 9.  Time course of induction of m  and J  chain-specific mRNA.  B cells stimulated 
with anti-IgM and T  cell-derived factors were harvested at 48, 72, and 96 h after the initiation 
of culture. In this experiment, BSF-pI  is a reverse phase HPLC-purified preparation; molec- 
ularly cloned IL-2 was used as EL-TRF. These cell populations were used for preparation of 
cytoplasmic RNA, and were also examined for the presence of B cells with cytoplasmic IgM. 
Numbers in parentheses are the percent of cytoplasmic IgM  ÷ cells in each group. As a negative 
control for activated B cells, cytoplasmic RNA was prepared from B cells cultured in medium 
containing no anti-IgM or T  cell-derived factors,  for 48  h.  Each preparation of RNA  was 
dotted onto a nitrocellulose filter and probed with either the #, or J  chain probe. The initial 
dot  contained the  amount  of cytoplasmic  RNA  obtained  from  l0  B cells;  subsequent dots 
contained twofold dilutions of this. Although not shown, a group of cells was stimulated with 
anti-lgM and BSF-p-1. These cells had levels of ~  and J chain mRNA and of cytoplasmic I gM  + 
cells similar to that of cells stimulated with anti-IgM, BSF-p-1, and B 15-TRF. 
Our results indicate that striking changes occur in the level of #s and J  chain 
mRNA in B cells stimulated with anti-IgM, BSF-pl, B15-TRF, and EL-TRF. As 
we have already shown, induction of high IgM synthesis rates in B cells cultured 
with anti-IgM depends upon the presence of each of these T  cell-derived factors. 
Thus, the striking increases in/J,m and J chain mRNA, and the increase in the #d 
/£m  mRNA  ratio  only  occur  in  B  cells  that  have  virtually  completed  their 
differentiation program. B 15-TRF, the early acting B cell differentiation factor, 
although essential for IgM synthesis and secretion, does not, by itself, cause an 
increase in/~ or J  chain mRNA levels in B cells stimulated with anti-IgM and 
BSF-p 1. 
How B15-TRF exerts its action on anti-IgM and BSFpl-treated B cells is also 
unresolved. Recently (17), we have shown that molecularly cloned human IL-2, 
used at high concentration, exerts EL-TRF activity. B cells cultured with anti- 1748  Ig RNA  EXPRESSION IN  STIMULATED B CELLS 
IgM  and  BSF-pl  display  small  numbers of IL-2  receptors,  as judged  by  the 
binding of mAb specific for the T  cell IL-2 receptor, and by binding of [3H]IL- 
2.  Treatment  of such  cells  with  B15-TRF  causes  a  modest  enhancement in 
receptor number,  but  whether this  change has physiologic significance is  not 
known. 
Our  results  reaffirm the  role  of IL-2  as a  B  cell  differentiation factor  by 
showing that  IL-2,  used at  100-1,000  U/ml,  causes striking,  dose-dependent 
induction of #s and J  chain mRNA, a clear increase in the #s/#m ratio, and the 
appearance of cells containing cytoplasmic IgM. 
In the system we used,  10-30%  of the cells cultured with anti-IgM and the 
three T  cell-derived factors possessed cytoplasmic IgM. This suggests that the 
#d#m mRNA ratio in  cells actually secreting IgM  may be substantially higher 
than  the  value  of 5.6  obtained  in  this  study.  We  cannot  yet  determine the 
contribution of the cells secreting IgM relative to those not secreting IgM in the 
#~/#m ratio, nor can we determine whether the secretory cells express lower #m 
content than the nonsecretory cells. Since 70% or more of the B cells are not 
synthesizing IgM at a high rate, continued high levels of #m RNA in these cells 
could obscure major changes in the secretory cells. 
Similarly, the low levels of #~ mRNA in B cells treated with anti-IgM and BSF- 
p l  (or with these stimulants together with B15- or EL-TRF) may reflect either 
(a) undetectahly low levels of cytoplasmic IgM in cells with #~, or (h) the presence 
of very small numbers of IgM-secreting cells that have very high #*/#m ratios. 
The change in relative level of #s mRNA when all factors are present is of the 
same order of magnitude as the increase in the percentage of cells with cyto- 
plasmic IgM. 
Resting B cells display small amounts of RNA that hybridize with each of the 
probes  used  here.  Stimulation  with  anti-IgM  and  BSF-pl  causes  a  striking 
enhancement in  #m  mRNA  per  cell.  However,  these  changes are  much  less 
significant when compared on the basis of constant amounts of RNA, suggesting 
that  the amounts of #m mRNA do not  increase substantially more than  total 
RNA levels. In support of this are the similar increases in several of the RNA 
examined, most importantly the mRNA for H-2L  d,  a  molecule not obviously 
connected with the B cell activation process. 
Finally, our results indicate a  very close association between #~ mRNA and J 
chain mRNA levels in these cells. This is strikingly illustrated by the time course 
of amplification of ~s and J chain mRNA and by their similar dependence on the 
concentration of IL-2 used as EL-TRF. In addition, the requirement for induc- 
tion of detectable levels of  J chain protein are the same as those required for the 
appearance of high rate IgM-synthesizing cells, as judged by counting cells with 
cytoplasmic IgM by immunofiuorescent staining. As shown elsewhere, these same 
requirements hold when the concentration of cytoplasmic IgM is measured by 
ELISA, Although we have not directly, measured IgM secretion, because of the 
presence of anti-IgM in our cultures, the high levels of#~ mRNA strongly suggest 
that a correlation between J  chain protein levels and IgM secretion also exists in 
this system. Thus, this result strongly supports the concept that common regu- 
latory signals are involved in triggeringJ chain production and IgM secretion in 
normal B cells (8). NAKANISHI  ET AL.  1749 
Summary 
An increase in mRNA encoding the secretory form of the #  heavy (H) chain 
(#s) and in the ratio of t~ mRNA to the mRNA encoding the membrane form of 
the #H chain (Urn) occurs in normal B cells stimulated with anti-IgM and BSF-pl 
together  with  the  two  B  cell  differentiation  factors  B15-TRF  and  EL-TRF. 
Stimulation of cells with anti-IgM and BSF-p 1 with either B 15- or EL-TRF causes 
no change in #s levels or  #s/~,Lm ratios.  The requirements for induction of high 
rate IgM synthesis in normal B cells stimulated with anti-IgM were precisely the 
same as those required for elevation of t~ mRNA levels and for increase in U,/Um 
mRNA ratios. A  very close correlation also exists between induction of mRNA 
for J  chain and  increase  in  #~ mRNA  levels.  Similarly,  the  increase  in J  chain 
protein concentration and percent of cells with cytoplasmic IgM were correlated 
to each other and to levels of #~ and J  chain mRNA. These results indicate that 
elevation of #, mRNA and/Z~/~m mRNA ratios occur in normal B cells only upon 
commitment  to  IgM  synthesis,  and  reaffirm  the  close  relation  between  IgM 
synthesis and the presence of  J  chain. 
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